Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-24-052260

Options or other derivatives

  • VP Clinical Reg Affairs acquired 149,818 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Thompson Jaye VP Clinical Reg Affairs 2024-12-24 Grant or award · Stock Options +149,818 299,636 D
Loading xslF345X05/ownership.xml…